Musculoskeletal Disorders
Latest News
Rheumatology Match Day results for 2024 follow trends of past years
Adult rheumatology remains popular, but pediatric rheumatology continues to be less successful, filling only 55% of programs.
Latest News
First referral guide issued for axial spondyloarthritis
The draft recommendations are a “good first step,” but more awareness around axial spondyloarthritis in the nonrheumatology community is also...
Latest News
Strength training promotes knee health, lowers OA risk
The association between strength training and less frequent knee pain, less radiographic OA, and less symptomatic OA was strongest in the older...
News from the FDA/CDC
FDA OKs first ustekinumab biosimilar
The drug has also been granted an interchangeability designation and has been approved for six indications.
News from the FDA/CDC
FDA approves ninth Humira biosimilar, with interchangeability
The drug, adalimumab-afzb (Abrilada), is the second adalimumab biosimilar approved with interchangeability status. It will be available in late...
News from the FDA/CDC
FDA approves first tocilizumab biosimilar
Tocilizumab-bavi (Tofidence) will offer a lower-cost option for patients with autoimmune conditions, the drug manufacturer, Biogen, stated.
Commentary
Should people who play sports pay higher medical insurance premiums?
I don’t like a society where anybody who tries to do something that takes risk winds up bearing extra cost for doing that.
Latest News
Treating fractures in elderly patients: Beyond the broken bone
Osteoporosis management can prevent fractures, and follow-up after fractures can prevent future breaks.
Feature
Humira biosimilars: Five things to know
The launch of eight adalimumab biosimilars so far in 2023 ended Humira’s 20-year monopoly, but it’s not clear yet if these discounted drugs will...
Latest News
All in stride: Few age limitations for joint replacement
Primary care physicians should ask patients if the pain affects their day-to-day lives and if they were unresponsive to nonsurgical treatments...
Latest News
‘Landmark’ trial shows opioids for back, neck pain no better than placebo
Opioids don’t relieve low back or neck pain in the short term and lead to worse outcomes in the long term.